LaparoscopicAppendectomy near Newburgh, NY

Biography: If you need assistance in Chinese (Mandarin & Cantonese), please call 646-317-6325. Visit Columbia Liver Asian Outreach Office (English | Mandarin) Tomoaki Kato, M.D., is a noted pioneer in multiple-organ transplantation, pediatric and adult liver transplantation. Dr. Kato is Surgical Director of Adult and Pediatric Liver and Intestinal Transplantation at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center and is a professor of surgery at Columbia University College of Physicians and Surgeons. Dr. Kato is known for unique and innovative surgeries for adults and children, including a six-organ transplant; a procedure called APOLT (auxiliary partial orthotopic liver transplantation) that resuscitates a failing liver by attaching a partial donor liver, making immunosuppressant drugs unnecessary and the first successful human partial bladder transplantation involving the transplant of two kidneys together with ureters connected to a patch of the donor bladder. In a highly publicized case, he led the first reported removal and re-implantation, or auto-transplantation, of six organs to excise a hard-to-reach abdominal tumor. Previously the director of pediatric liver and gastrointestinal transplant and professor of clinical surgery at the University of Miami School of Medicine, Dr. Kato received his medical degree from the Osaka University Medical School in Japan and received his residency training in surgery at Osaka University Hospital and Itami City Hospital in Hyogo, Japan. He completed a clinical fellowship in transplantation at the University of Miami/Jackson Memorial Hospital, in Miami, Florida, where he was subsequently appointed to the surgical faculty in 1997, and promoted to full professor in 2007. He served as a surgeon and senior leader of the liver and transplantation center at Miami's Jackson Memorial Hospital, beginning in 1997, and at University of Miami Hospital (previously Cedars Medical Center), beginning in 2004. Dr. Kato is a member of numerous professional and honorary organizations, and the author or co-author of more than 180 scientific papers in peer-reviewed journals. Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver

Biography: Makram Gedeon, MD, is a double board-certified bariatric and colorectal surgeon specialized in minimally-invasive approaches to colorectal and bariatric surgery. Dr. Gedeon is part of both the Colorectal Surgery team at several locations throughout New York and New Jersey and the Center for Advanced Surgery at Lawrence Hospital and Hudson Valley. Dr. Gedeon received his medical degree from the American University of Beirut in 2002 before completing an internship in surgery at the Mayo Clinic and a general surgery residency at the University of Texas Southwestern. He has undergone two fellowships - one in minimally-invasive surgery at the University of Texas Southwestern and another in colon and rectal surgery at NewYork-Presbyterian. Following his residency training, Dr. Gedeon spent ten years in a busy community hospital practice in Bristol, Connecticut, where he helped start and grow the practice's weight loss surgery program and served as its medical director until the end of 2018. Clinically, Dr. Gedeon is interested in the application of minimally-invasive and robotic surgery to treat colorectal diseases and obesity, specializing in bariatric surgery and revisions. His research focuses include surgical technology and clinical outcomes. He is fluent in English, Arabic and French.

Biography: Dr. Emond is the Vice Chairman of Surgery at Columbia University. He has over 30 years of experience performing liver transplantation and complex liver and biliary surgery in children and adults, including the first living donor liver transplantation (LDLT) in the United States. Dr. Emond has published extensively in this field and was the co-chair of the NIH A2ALL program for 13 years. In collaboration with the department of Medicine at Columbia, Dr. Emond recruited the leadership of the Columbia Center for Translational immunology that created the foundation for translational and clinical research in transplantation tolerance. This will lead the way to inducing transplant tolerance in liver patients with the mixed chimerism strategy. As Director of Transplantation at the Columbia University Medical Center Dr. Emond's activities foster clinical excellence and research across all 11 of the solid organ transplant programs at the Medical Center. In recognition of his national and international leadership in transplantation, Dr. Emond is the past president of the American Society of Transplant Surgeons, the pre-eminent association of a transplant surgery. Contribution to Science Living donor liver transplantation Dr. Emond has spent a substantial portion of his career developing living donor liver transplantation and studying the safety of the procedure in both the donor and recipient. He participated in the first living donor liver transplant in the United States and focused on refining the techniques of performing living donor liver transplants and split liver transplants. He was the national co-chair of the NIH-sponsored Adult-to-Adult Living Donor Liver Transplantation (A2ALL) consortium from 2002 to 2015 to study the safety and outcomes of living donor liver transplants. Hepatic resection/ischemia Dr. Emond developed techniques for surgical resection of liver tumors and studied the effect of ischemia during resection on postoperative liver function. These studies include the outcomes of the extent of hepatectomy, the biochemical response to major hepatectomy and ischemia-reperfusion injury of the liver in rodent models. He has studied the clinical safety of inducing total vascular exclusion to provide a bloodless field during the liver transection. This has applications in both liver cancer and living donor hepatectomies. Hepatocellular carcinoma treatment Dr. Emond has studied many aspects of managing patients with hepatocellular carcinoma. These studies have included characterizing the risk factors for recurrence of disease following transplantation due to comorbidities and tumor characteristics. The research team has also studied the optimal method of preventing tumor growth in patients with HCC on the liver transplant wait list in addition to optimal strategies of liver allocation to optimize outcomes following liver transplantation. These studies have contributed to proposed changes in UNOS exception point allocation for liver transplant candidates with HCC. Pediatric liver transplantation Dr. Emond helped develop the field of pediatric liver transplantation. Contributions to this field include: the use of living donors for pediatric patients; use of auxiliary liver transplants for metabolic diseases; use of partial liver grafts for pediatric patients; and technical modifications that improved outcomes for this patient population. Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Subhash Krishnamoorthy is a dual trained physician in general surgery and critical care medicine. He was born in India and raised in Hamilton, Ontario. He received his undergraduate degree in Medical & Health Physics at McMaster University. He completed his General Surgery residency and a fellowship in Critical Care Medicine at Columbia University New York Presbyterian Hospital. He joined the faculty as Assistant Professor of Surgery in 2018. His focus is centered on providing surgical solutions to acutely and critically ill patients. This extends from acute care surgery and surgical critical care to extracorporeal membrane oxygenation in respiratory and cardiac failure. He is passionate about patient-centered medicine, medical education, and collaborative initiatives to improve the quality of care.